Lexicon Pharmaceuticals
LXRX
#7247
Rank
S$0.62 B
Marketcap
S$1.71
Share price
0.76%
Change (1 day)
74.38%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.11 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's total liabilities are S$0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lexicon Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.20 B15.11%
2023-12-31S$0.18 B74.01%
2022-12-31S$0.10 B228.25%
2021-12-31S$31.51 M-49.76%
2020-12-31S$62.72 M-84.52%
2019-12-31S$0.40 B-4.47%
2018-12-31S$0.42 B-13.87%
2017-12-31S$0.49 B6.95%
2016-12-31S$0.46 B-11.07%
2015-12-31S$0.51 B109.19%
2014-12-31S$0.24 B87.89%
2013-12-31S$0.13 B2.52%
2012-12-31S$0.12 B-25.35%
2011-12-31S$0.17 B11.51%
2010-12-31S$0.15 B16.67%
2009-12-31S$0.13 B40.89%
2008-12-31S$93.93 M-21.09%
2007-12-31S$0.11 B-25.9%
2006-12-31S$0.16 B-27.41%
2005-12-31S$0.22 B50.08%
2004-12-31S$0.14 B-26.44%
2003-12-31S$0.20 B262.49%
2002-12-31S$55.29 M38.18%
2001-12-31S$40.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Eterna Therapeutics
ERNA
S$3.36 M-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$11.91 B 10,640.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S$1.51 B 1,269.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$2.01 B 1,716.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$67.08 B 60,372.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$1.05 B 850.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$4.90 B 4,325.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.68 B 513.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
S$0.69 B 529.11%๐Ÿ‡บ๐Ÿ‡ธ USA